F-18-Fludeoxyglucose

Fludeoxyglucose F-18 · Fedoruk Centre for Nuclear Innovation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for F-18-Fludeoxyglucose, covering 2017-05-04 to 2017-05-04. Get the full timeline:

Most recent: Clinical Trial Update: Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose [Phase 4]

See pricing